| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.04 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.04 |